MAP 2018: Abstracts

Abstract submission deadlines

Deadline Date and time
Abstracts Now until 5 July 2018, 21:00 CEST (Central European Summer Time)

Submit Your Abstract

Outcome notifications

Outcome notifications are expected to be made available to first authors by mid-July 2018.

Trial in Progress abstracts

Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) may be submitted to MAP 2018.

It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis and consequently will only require the completion of two (2) sections:

  • Background
  • Trial design

Notes:

  • Recruitment must have already begun or have been completed by the abstract submission deadline of 5 July 2018.
  • Abstracts including results or preliminary data will be rejected.
  • Authors of ‘encore’ TiP abstract submissions must supply information regarding the original presentation, indicating the name of the meeting and publication number. The first author will be responsible for obtaining, and, upon request, showing proof that written permission has been obtained from the copyright holder of the original abstract publication(s).
  • Trial in Progress abstracts will be accepted for Poster outcome only.

Abstracts will be reviewed by the MAP 2018 Scientific Committee and considered on the merits of the scientific and clinical rationale of the trial.

Presentation of accepted abstracts

The MAP 2018 Scientific Committee will select abstracts for presentation during the Congress and determine the format of the presentations from the following possibilities:

  • Proffered Paper (oral presentation) – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.
  • Poster – An important method for communicating details of scientific research, posters will be on display for the duration of the Congress.

Publications

All accepted abstracts will be published as a supplement to the official ESMO journal Annals of Oncology.

Travel grants

A restricted number of travel grants to MAP 2018 are available, upon application, to first author (= presenter) of candidates under the age of 40 who submit abstracts considered deserving of recognition. Selection will be made by the MAP 2018 Scientific Committee on a competitive basis from among the accepted abstracts.

To apply for a travel grant, the following documents must be received by the ESMO Scientific Affairs Department on or before 5 July 2018:

  1. A letter of introduction by the applicant. Please include the following general information
    • How relevant are the topics presented during this Congress to your current practice and research?
    • Have you attended any event on a similar topic in the last 3 years?
    • How do you believe your attendance at this Congress will help you improve your knowledge in the field and your professional development?
    • How do you consider that the findings published in your abstract make a relevant contribution to the topics presented during this Congress?
    • Have you recently been awarded an ESMO travel grant? If yes, for which event?
  2. A copy of the submitted abstract (the applicant must be the first author and presenter)
  3. A readable photocopy of either identity card or passport
  4. A short curriculum vitae (maximum 2 pages)

Documentation must be sent by e-mail to  travelgrants@esmo.org

The ESMO Scientific Affairs Department will provide the recipients with a subsidised travel ticket, subsidised accommodation and Congress registration.

Travel grant recipients must submit a report detailing the benefits of participating in MAP 2018 by 15 December 2018.

Incomplete applications will not be considered.